Characterization of transforming growth factor-β-resistant subclones isolated from a transforming growth factor-β-sensitive human colon carcinoma cell line

Kathleen M. Mulder, Mary K. Ramey, Naseema M. Hoosein, Alan E. Levine, Xochil H. Hinshaw, Diane E. Brattain, Michael G. Brattain

Research output: Contribution to journalArticle

40 Scopus citations

Abstract

Previous work indicated that transforming growth factor-β (TGF-β) elicits proliferation-inhibitory effects in the human colon carcinoma cell line MOSER. This paper describes the isolation and characterization of spontaneously arising subclones from this TGF-β-sensitive parental line which were relatively refractory to the inhibitory effects of TGF-β. While the parental cell line responded to TGF-β with an inhibition of cellular proliferation in monolayer culture and in soft agarose, an increase in extracellular fibronectin, and a down-regulation of c-myc protooncogene expression, these responses were absent or attenuated in the sublines. However, the resistant clones retained the ability to specifically bind TGF-β. N,N-Dimethylformamide and retinoic acid two other agents associated with induction of a partial differentiation-like response in the MOSER parental cells (similar to that elicited by TGF-βX inhibited the monolayer proliferation of both the parental cells and the TGF-β-resistant sublines. Thus, the refractoriness observed in the isolated clones was relatively specific for TGF-β.

Original languageEnglish (US)
Pages (from-to)7120-7125
Number of pages6
JournalCancer Research
Volume48
Publication statusPublished - Dec 1 1988

    Fingerprint

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Mulder, K. M., Ramey, M. K., Hoosein, N. M., Levine, A. E., Hinshaw, X. H., Brattain, D. E., & Brattain, M. G. (1988). Characterization of transforming growth factor-β-resistant subclones isolated from a transforming growth factor-β-sensitive human colon carcinoma cell line. Cancer Research, 48, 7120-7125.